Stock listing

NASDAQ:AEGR Aegerion Pharmaceuticals Inc Stock

Follow Aegerion Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:AEGR

$1.97 USD

Close on Nov 29, 2016 · No longer trades

Oct 22, 2010 to last close -81.8% · weekly closes, Oct 22, 2010 – Nov 29, 2016
Lowest – highest close
$1.26 – $97.24 USDSince Oct 22, 2010 · lowest Jun 13, 2016 · highest Oct 4, 2013

Delisted NASDAQ:AEGR no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:AEGR
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Aegerion Pharmaceuticals Inc on 6ix

Decks
2 decks · latest Aug 10, 2016

Decks

DeckKindSlidesDate
Merger or Acquisition (August 2016)Merger or acquisition9 slidesAug 10, 2016
Merger or Acquisition (June 2016)Merger or acquisition15 slidesJun 16, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sol J. Barer
Other companies: Teva Pharmaceutical Industries Limited (Director · Since at least Jan 1, 2018); NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Avalo Therapeutics, Inc. (Director · Feb 3, 2020 – Jun 15, 2021 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); CervoMed Inc. (Director · Nov 1, 2013 – Jul 24, 2014 · Past); Aevi Genomic Medicine LLC (Director · Jun 30, 2012 – Feb 3, 2020 · Past); InspireMD Inc. (Director · Jul 11, 2011 – Dec 7, 2016 · Past); Amicus Therapeutics Inc (Director · Jan 6, 2009 – Jun 9, 2016 · Past); Celgene Corporation (Director · Dec 31, 2005 – Jan 13, 2011 · Past)
Director · May 1, 2011 – Nov 29, 2016 · Past
Anne Marie Cook
Other companies: Phathom Pharmaceuticals, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Jun 23, 2025); Sage Therapeutics Inc (SVP, GC & Secretary · Sep 16, 2015 – Aug 5, 2024 · Past)
SVP, General Counsel · Dec 5, 2011 – Aug 4, 2015 · Past
Antonio M Md D Phil Gotto Jr
Other companies: Esperion Therapeutics, Inc. (Director · Jan 13, 2014 – May 23, 2024 · Past); Medtronic plc. (Director · Aug 24, 2006 – Aug 24, 2006 · Past)
Director · Oct 21, 2010 – Nov 29, 2016 · Past
Barbara Y Chan
Other companies: Omega Therapeutics Inc (Chief Accounting Officer · May 31, 2024 – May 31, 2024 · Past); Novelion Therapeutics Inc (See Remarks · Nov 29, 2016 – Sep 24, 2019 · Past)
VP, Chief Accounting Officer · Jun 1, 2016 – Nov 29, 2016 · Past
Jorge MD Plutzky
Other companies: Novelion Therapeutics Inc (Director · Nov 29, 2016 – Dec 22, 2016 · Past); VIVUS Inc (Director · Apr 29, 2016 – Feb 20, 2020 · Past)
Director · Nov 29, 2016 – Nov 29, 2016 · Past
Mary Weger
Other companies: ProKidney Corp. (Chief People Officer · Dec 1, 2022 – Jan 16, 2023 · Past); Medidata Solutions Inc (EVP, Human Resources · Feb 23, 2017 – Feb 24, 2017 · Past)
Chief Performance Officer · Mar 29, 2015 – Aug 4, 2015 · Past
Craig Fraser
Other companies: Windtree Therapeutics, Inc. (President and CEO, Director · Jul 28, 2016 – Oct 8, 2024 · Past)
Chief Operating Officer · Sep 3, 2012 – Apr 1, 2015 · Past
Eric Curtis
Other companies: Windtree Therapeutics, Inc. (SVP & COO · Mar 9, 2020 – Aug 23, 2023 · Past)
President, U.S. Commercial · Aug 26, 2015 – Aug 26, 2015 · Past
Linda Buono
Other companies: Novelion Therapeutics Inc (Sr. VP, Human Resources · Nov 29, 2016 – May 9, 2019 · Past)
Sr. VP, Human Resources · Aug 30, 2016 – Nov 29, 2016 · Past
Martha J Carter
Other companies: Albireo Pharma Inc (Chief Regulatory Officer · Nov 28, 2016 – Mar 2, 2023 · Past)
See Remarks · Aug 4, 2015 – May 9, 2016 · Past
All 13 people
PersonSeat
Michele Ollier
Other companies: Minerva Neurosciences, Inc (Director · Jun 30, 2014 – Dec 12, 2016 · Past)
Director · Oct 21, 2010 – Jul 29, 2011 · Past
Remi A Menes
Other companies: Novelion Therapeutics Inc (See Remarks · Nov 29, 2016 – Dec 22, 2016 · Past)
Global Chief Commercial Off. · Sep 12, 2016 – Sep 12, 2016 · Past
Mark SumerayChief Medical Officer · Aug 4, 2015 – Aug 4, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Aegerion Pharmaceuticals Inc.